KYQG exhibited the therapeutic effects on oral ulcers probably by inhibiting inflammation, regulating immunological response, and suppressing oxidative stress based on 47 key targets, such as MMP9, COX2, and TNF-α. The gene discussed is PTGS2; the disease is Oral ulcer.